Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision version updated to v3.6.6, replacing v3.6.5, indicating a minor site update without altering study data.
    Difference
    0.0%
    Check dated 2026-08-29T23:41:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the site. This represents a minor platform update with no changes to the study details or on-page content.
    Difference
    0.0%
    Check dated 2026-08-08T23:20:18.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.3 to v3.6.4. This appears to be a maintenance update with minor fixes that do not change the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T16:56:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page, signaling a new version of the site's content or template. This is an internal update and does not alter the study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-07-04T04:27:57.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, signaling a new site/documentation release. This reflects backend/versioning updates rather than changes to study details or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-27T02:48:22.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Enrollment is closed as indicated by the new status. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling and revision version to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:50:41.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.